Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints
ChemMedChem · 2026-10-28 · 21 (20)
DOI: 10.1002/cmdc.70533 ↗At a glance
Übersichtsarbeit in ChemMedChem, published online on 2026-10-14. Written by Banty Kumar and 5 co-authors. Institution: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Etawah, U.P., India. Major MEDLINE topics: Proto-Oncogene Proteins c-pim-1, Antineoplastic Agents, Signal Transduction, Protein Kinase Inhibitors. 101 references.
Abstract (original language)
Pim‐1, a carcinogenic threonine and serine kinase, inhibits apoptosis and advances the cell cycle. It is overexpressed in several human cancers. The proviral integration site of Moloney murine leukemia virus 1 is Pim‐1. Previous studies have shown that the Pim‐1 30‐UTR regulates the stability of Pim‐1 mRNA. Threonine and serine are identified as the proto‐oncogene Pim‐1 kinase. Pim‐1 mediates numerous biological processes, including apoptosis, cell division, proliferation, and cancer. Pim‐1‐mediated anticancer activity has been reported in several analogs of thiazole/ bis ‐thiazole, tetrazine, thiophenes, quinoline, pyrazolopyrimidine, 3‐cyanopyridine, thiazolidine‐2,4‐dione, thieno[2,3‐ b ]pyridine, triazolo[4,3‐ b ]pyridazine, pyrazolo[1,5‐ a ]pyrimidines, and pyrazolo[3,4‐ b ]pyridine derivatives. Additionally, flavonoids and amino alcohol compounds that constitute Pim‐1‐mediated cancer therapy have also been identified thus far. Many compounds with Pim‐1‐mediated cytotoxicity have been discovered up to this point, and scientists are currently concentrating on bringing novel compounds with anticancer potential to the market.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Uttar Pradesh University of Medical Sciences, Etawah, U.P., India.
- Sir Madanlal Institute of Pharmacy, Etawah, U.P., India.
- School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar, Punjab, India.
- Department of Pharmaceutical Chemistry and Analysis, ISF College of Pharmacy, Moga, Punjab, India.
ORCID profiles: Ankur Vaidya, Shweta Jain, Sanjeev Kumar Sahu, Preeti Patel, Vivek Asati
Cite
APA
Kumar, B., Vaidya, A., Jain, S., Sahu, S. K., Patel, P., & Asati, V. (2026). Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints. ChemMedChem, 21(20). https://doi.org/10.1002/cmdc.70533
Vancouver
Kumar B, Vaidya A, Jain S, Sahu SK, Patel P, Asati V. Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints. ChemMedChem. 2026;21(20). doi:10.1002/cmdc.70533
BibTeX
@article{Kumar2026,
author = {Kumar, Banty and Vaidya, Ankur and Jain, Shweta and Sahu, Sanjeev Kumar and Patel, Preeti and Asati, Vivek},
title = {Inhibitors of PIM‐1 Signaling Pathways as Anticancer Agents: Pharmacological and Structural Viewpoints},
journal = {ChemMedChem},
year = {2026},
volume = {21},
number = {20},
doi = {10.1002/cmdc.70533}
}
EUVIMED